Fabiana Gentilini
- Hematology top 5%
- Molecular Biology
- Genetics top 10%
- Oncology
- Biochemistry
- Co-authors
- Massimo BrecciaRoberto LatagliataIda CarmosinoGiuliana AlimenaFranco MandelliGiuseppe CiminoAnna GuariniFrancesco Lo‐Coco
- Topics
- Multiple Myeloma Research and Treatments (11 papers)Protein Degradation and Inhibitors (7 papers)Peptidase Inhibition and Analysis (6 papers)
- Cited by
- HematologyGeneticsInternal Medicine
- Partner nations
- ItalyNetherlandsMalaysia
In The Last Decade
Fabiana Gentilini
20 papers receiving 289 citations
Peers
Comparison fields: 5 of 39
- Hematology 232
- Molecular Biology 148
- Genetics 91
- Oncology 73
- Biochemistry 37
Countries citing papers authored by Fabiana Gentilini
This map shows the geographic impact of Fabiana Gentilini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabiana Gentilini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabiana Gentilini more than expected).
Fields of papers citing papers by Fabiana Gentilini
This network shows the impact of papers produced by Fabiana Gentilini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabiana Gentilini. The network helps show where Fabiana Gentilini may publish in the future.
Co-authorship network of co-authors of Fabiana Gentilini
This figure shows the co-authorship network connecting the top 25 collaborators of Fabiana Gentilini. A scholar is included among the top collaborators of Fabiana Gentilini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabiana Gentilini. Fabiana Gentilini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | WEEKLY CARFILZOMIB, CYCLOPHOSPHAMIDE AND DEXAMETHASONE (WKCYD) FOLLOWED BY MAINTENANCE WITH WEEKLY CARFILZOMIB (WK) IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) | 2 |
| 3 | 1 | |
| 4 | 4 | |
| 5 | 11 | |
| 6 | 5 | |
| 7 | 7 | |
| 8 | 4 | |
| 9 | 10 | |
| 10 | 19 | |
| 11 | 23 | |
| 12 | 9 | |
| 13 | 5 | |
| 14 | 1 | |
| 15 | 31 | |
| 16 | 26 | |
| 17 | 90 | |
| 18 | 6 | |
| 19 | 17 | |
| 20 | 9 |
About Fabiana Gentilini
Fabiana Gentilini is a scholar working on Hematology, Genetics and Complementary and alternative medicine, having authored 22 papers that have together received 296 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (11 papers), Protein Degradation and Inhibitors (7 papers) and Peptidase Inhibition and Analysis (6 papers). The work is most often cited by research in Hematology (232 citations), Genetics (91 citations) and Internal Medicine (28 citations). Fabiana Gentilini has collaborated with scholars based in Italy, Netherlands and Malaysia. Frequent co-authors include Massimo Breccia, Roberto Latagliata, Ida Carmosino, Giuliana Alimena, Franco Mandelli, Giuseppe Cimino, Anna Guarini, Francesco Lo‐Coco, Maria Stefania De Propris and M C Petti. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.